GLP-1 Peptides: The Weight Loss Mechanism
GLP-1 (glucagon-like peptide-1) receptor agonists are the most effective class of weight loss medications available. They work by mimicking a gut hormone that:
- Signals satiety to the brain — you feel full faster and stay full longer
- Slows gastric emptying — food moves through the stomach more slowly
- Reduces appetite at the neurological level — food cravings decrease
- Improves insulin sensitivity and glucose metabolism
The result is a significant reduction in caloric intake without the psychological battle of traditional dieting. Clinical trials show 15–20% body weight reduction — substantially greater than any previous weight loss medication class.
FDA-approved GLP-1 receptor agonist (same mechanism as Ozempic and Wegovy). Reduces appetite, slows gastric emptying, and improves insulin sensitivity. Compounded semaglutide delivers identical active ingredient at 60–80% lower cost than brand-name versions. Weekly subcutaneous injection.
Typical results
15–20% average body weight reduction at 6 months in clinical trials
TN cost
$150–400/month (compounded)
Note
Compare: Ozempic/Wegovy can run $900–1,400/month without insurance
A modified fragment of human growth hormone specifically designed to stimulate fat metabolism without the growth-promoting effects of full HGH. AOD-9604 activates fat-burning pathways and inhibits fat production. Lower side-effect profile than semaglutide; often used for patients who can't tolerate GLP-1 side effects.
Typical results
More modest weight loss than semaglutide; best for body recomposition alongside exercise
TN cost
$100–200/month
Note
Often stacked with ipamorelin for simultaneous fat loss and lean mass gain
Compounded vs. Brand Name: The Cost Reality
Brand Name (Ozempic / Wegovy)
$900–1,400/month
Without insurance. With insurance, prior authorization and step therapy often required. Coverage denial is common for weight loss indication.
Compounded Semaglutide (TN)
$150–400/month
Same active ingredient. Licensed compounding pharmacy. Requires physician prescription. Price varies by dose and pharmacy.
What to Expect: Realistic Timeline
- Week 1–4: Starting dose. Most patients notice appetite reduction immediately. Nausea is common during this phase and typically improves.
- Week 4–12: Dose escalation phase. Weight loss accelerates as dose increases. Average 1–2 lbs/week for most patients.
- Month 3–6: Therapeutic dose. Most significant weight loss period. 8–15% body weight reduction typical by month 6.
- Month 6+: Maintenance or continued reduction. Physician will assess whether to continue, hold, or taper.